Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled DNase for infants hospitalized with RSV bronchiolitis
NL-OMON20249Active, not recruiting
- Start
- Dec 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of dornase alfa in respiratory syncytial virus bronchiolitis (2 arms). Primary endpoints: Length of stay and Symptom score. Started Dec 2002; status: active, not recruiting.
02
Drugs
dornase alfa
03
Conditions
respiratory syncytial virus bronchiolitis
Beyond the preview
Go deeper on NL-OMON20249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20249.